Header cover image

French Pharmaceuticals & Biotech Buy the Dip

Results

1

1 new

Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.

1 companies

DBV Technologies

Market Cap: €704.3m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

New

DBV

€2.38

7D

-8.5%

1Y

39.8%